A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.
Clinical trial NCT06175143 · UNKNOWN
Trial details
- NCT number
- NCT06175143
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.